Preclinical biomarkers for a cyclin-dependent kinase...

Molecular Cancer Therapeutics 2009 / 09 Vol. 8; Iss. 9

Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients

Berkofsky-Fessler, W., Nguyen, T. Q., Delmar, P., Molnos, J., Kanwal, C., DePinto, W., Rosinski, J., McLoughlin, P., Ritland, S., DeMario, M., Tobon, K., Reidhaar-Olson, J. F., Rueger, R., Hilton, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-09-0083
Date:
September, 2009
File:
PDF, 423 KB
english, 2009
Conversion to is in progress
Conversion to is failed